Your Article Summary
See Latest ArticlesPsychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk
The Journal of Headache and Pain, 06/29/09
Pompili M et al. - This review will focus on the way in which psychiatric disorders decrease the quality of life and result in a worse prognosis, chronicity of the disease, and a worse response to treatment. Short-term pharmaceutical care intervention improves the patients’ mental health, but it does not significantly change the number and severity of headaches. The increase in self-efficacy and mental health associated with pharmaceutical care may be instrumental in improving the long-term pharmacotherapy of patients with migraine and headache.
Related Articles
Psychiatric comorbidity and suicidal behavior in epilepsy: A community-based case–control study
Epilepsia, 11/05/09
Relevance Score: 66%
Predictive Values of Psychiatric Symptoms for Internet Addiction in Adolescents
Archives of Pediatrics and Adolescent Medicine, 10/07/09
Relevance Score: 65%
Characteristics and Concordance of Autism Spectrum Disorders Among 277 Twin Pairs
Archives of Pediatrics and Adolescent Medicine, 10/08/09
Relevance Score: 64%
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Relevance Score: 46%
Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients
Head & Neck, 10/15/09
Relevance Score: 46%
Today in Headache...keeping you current
Receive free subspecialty "5-minute updates" via email
Is botulinum toxin useful in treating headache? No
Current Treatment Options in Neurology, 12/17/09
Bilateral Acute Angle-closure Glaucoma in a Migraine Patient Receiving Topiramate: A Case Report
The Journal of Emergency Medicine, 12/17/09
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Pharmacology & Therapeutics, 12/17/09